Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma.
Tanaka N, Mori S, Kiyotani K, Ota Y, Gotoh O, Kusumoto S, Nakano N, Suehiro Y, Ito A, Choi I, Ohtsuka E, Hidaka M, Nosaka K, Yoshimitsu M, Imaizumi Y, Iida S, Utsunomiya A, Noda T, Nishikawa H, Ueda R, Ishida T.
Tanaka N, et al. Among authors: kusumoto s.
Haematologica. 2022 Oct 1;107(10):2418-2431. doi: 10.3324/haematol.2021.280352.
Haematologica. 2022.
PMID: 35417939
Free PMC article.